Bio-IT World & CHI

Impact of the 1000 Genomes Project on the Next Wave of Pharmacogenomic Discovery
Interview with M. Eileen Dolan, Ph.D., Professor, Medicine, University of Chicago and Speaker at Next-Generation Sequencing Data Management, September 27-29, 2010, Providence, RI  

The 1000 Genomes Project aims to provide detailed genetic variation data on >1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International Hap-Map samples that are composed of lymphoblastoid cell lines (LCLs) derived from individuals of different world populations. The detailed map of human genetic variation promised by the 1000 Genomes project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource can greatly enhance our understanding of the genetic basis of drug response and other complex traits.

Download Now 

Recognizing the Key Role of IT in Empowering Translational Research
Sponsored by:  HP

To effectively bring products to market quickly and increase the pipeline of potential new therapeutics, life science enterprises must apply research insights to bridge the information gap between research and clinical care. In this session, you’ll gain an experts view of why a successful IT infrastructure can be a quick win for R&D and lay the groundwork for better drug discovery and personalized medicine.

Key discussion topics:
• IDC Health Industry Insights’ view of today’s Translational Research landscape
• Strategic impact of an extensible, SOA-based IT framework for R&D collaboration and translational research
• HP’s Digital Life Sciences portfolio, technology and services facilitating translational research and increased collaboration across the life sciences ecosystem

Download the webcast (recorded LIVE Tuesday, April 13th, 1pm EST)